Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 6 months ago

Possible Interaction: Epigallocatechin Gallate and Celecoxib

Research Papers that Mention the Interaction

The synergistic enhancements of apoptosis and GADD153 gene expression in human non‐small cell lung cancer cells by the combination of EGCG and celecoxib were mediated through the activation of the MAPK signaling pathway.
Cancer science  •  2011  |  View Paper
Celecoxib and EGCG synergistically reduced IL-1-induced production of pro-inflammatory IL-6 and pro-angiogenic IL-8 to 23-50%.
Thus, in Colo357, EGCG synergistically boosts celecoxib-mediated effects and reduces the levels of celecoxib required to elicit beneficial effects on tumorigenic mediators by a factor of ten.
We found that co-incubation of Colo357 with celecoxib and EGCG synergistically diminished metabolic activity via apoptosis induction and down-regulated release of pro-angiogenic vascular endothelial growth factor (VEGF) and invasiveness-promoting matrix metalloproteinase (MMP)-2 to a maximum of 30%.
European journal of pharmacology  •  2012  |  View Paper
Judging by upregulation of GADD153, only cotreatment with EGCG plus celecoxib synergistically induced apoptosis of PC‐9 cells.
We specifically looked for induction of apoptosis and expression of apoptosis related genes, with emphasis … damage‐inducible 153 (GADD153) gene, in human lung cancer cell line PC‐9: Cotreatment with EGCG … celecoxib strongly induced the expression of both GADD153 mRNA level … cells, while neither EGCG nor celecoxib alone did.
International journal of cancer  •  2006  |  View Paper
At sacrifice (19 weeks of age), treatment with both celecoxib (74% inhibition, P<0.01) and EGCG (71% inhibition, P<0.05) significantly inhibited the development of colitis-associated colon tumors.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation  •  2015  |  View Paper